Evoke Pharma Inc reports results for the quarter ended in March - Earnings Summary

Evoke Pharma

10/05/2022 22:49

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted
loss
of 7 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 4 cents per
share.
    * Revenue rose 364.9% to $418.38 thousand from a year ago; 
analysts expected $535.00 thousand. 
    * Evoke Pharma Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Evoke Pharma Inc shares had fallen by 24.3% this
quarter and
lost 31.9% so far this year.
    * The company reported a quarterly loss of $2.17 million.
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 09:48 p.m.  ​All
figures in US dollars unless otherwise stated